Estimating background rates of Guillain-Barr-Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign

Deeks, Shelley L.; Lim, Gillian H.; Simpson, Mary Anne; Rosella, Laura; Mackie, Christopher O.; Achonu, Camille; Crowcroft, Natasha S.
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p329
Academic Journal
Background: The province of Ontario, Canada initiated mass immunization clinics with adjuvanted pandemic H1N1 influenza vaccine in October 2009. Due to the scale of the campaign, temporal associations with Guillain- Barré syndrome (GBS) and vaccination were expected. The objectives of this analysis were to estimate the number of background GBS cases expected to occur in the projected vaccinated population and to estimate the number of additional GBS cases which would be expected if an association with vaccination existed. The number of influenza-associated GBS cases was also determined. Methods: Baseline incidence rates of GBS were determined from published Canadian studies and applied to projected vaccine coverage data to estimate the expected number of GBS cases in the vaccinated population. Assuming an association with vaccine existed, the number of additional cases of GBS expected was determined by applying the rates observed during the 1976 Swine Flu and 1992/1994 seasonal influenza campaigns in the United States. The number of influenza-associated GBS cases expected to occur during the vaccination campaign was determined based on risk estimates of GBS after influenza infection and provincial influenza infection rates using a combination of laboratory-confirmed cases and data from a seroprevalence study. Results: The overall provincial vaccine coverage was estimated to be between 32% and 38%. Assuming 38% coverage, between 6 and 13 background cases of GBS were expected within this projected vaccinated cohort (assuming 32% coverage yielded between 5-11 background cases). An additional 6 or 42 cases would be expected if an association between GBS and influenza vaccine was observed (assuming 32% coverage yielded 5 or 35 additional cases); while up to 31 influenza-associated GBS cases could be expected to occur. In comparison, during the same period, only 7 cases of GBS were reported among vaccinated persons. Conclusions: Our analyses do not suggest an increased number of GBS cases due to the vaccine. Awareness of expected rates of GBS is crucial when assessing adverse events following influenza immunization. Furthermore, since individuals with influenza infection are also at risk of developing GBS, they must be considered in such analyses, particularly if the vaccine campaign and disease are occurring concurrently.


Related Articles

  • Guillain-Barré-Syndrom nach Exposition mit Influenza. Hartung, H.-P.; Keller-Stanislawski, B.; Hughes, R.A.; Lehmann, H.C. // Der Nervenarzt;Jun2012, Vol. 83 Issue 6, p714 

    Guillain-Barré Syndrome (GBS) is an acquired, monophasic inflammatory polyradiculoneuritis of autoimmune origin, which occurs after infection and occasionally also after vaccination. Seasonal and pandemic influenza vaccines have in particular been implicated as triggers for GBS. However, a...

  • Swine Flu Vaccine Fearmongering. Hall, Harriet // Skeptic;2010, Vol. 15 Issue 3, p16 

    The article presents analyses, evaluations, and scientific explanations on the misinformation and misrepresent claims of some individuals about swine-flu cases and vaccines. It mentions the claim that vaccines for Guillain-Bare Syndrome (GBS) are only 75% effective in preventing the patient for...

  • Should I have an H1N1 flu vaccination after Guillain-Barré syndrome? Price, Laura Claire // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/12/2009, Vol. 339 Issue 7721, p635 

    The author assesses whether she should be vaccinated against H1N1 flu after developing Guillain-Barré syndrome. She cites studies which examined the risk of recurrent Guillain-Barré syndrome after the vaccination. An explanation of why the vaccine might cause the syndrome is also offered....

  • Small risk of Guillain-Barré syndrome with H1N1 2009 vaccines.  // Reactions Weekly;03/23/2013, Issue 1445, p2 

    The article reports that according to the results of a large meta-analysis in the U.S., influenza A (H1N1) 2009 monovalent inactivated vaccines contributed in slightly increasing the risk of Guillain-Barr'e syndrome (GBS).

  • HIN1 vaccine given to pregnant women not linked to GBS, poor birth outcomes.  // Infectious Disease News;Aug2012, Vol. 25 Issue 8, p28 

    The article discusses the two separate studies that contrasts findings regarding the safety of influenza A(H1N1) vaccine given to pregnant women and risk of Guillain-Barré syndrome (GBS) among adults.

  • Slight risk for Guillain-Barré syndrome attributed to HIN1 vaccine.  // Infectious Disease News;Apr2013, Vol. 26 Issue 4, p25 

    The article discusses the results of a study conducted by Dr. Bruce Gellin and colleagues and published in the "Lancet" journal regarding the association between the development of Guillain-Barré syndrome and the administration of influenza A (H1N1) 2009 monovalent inactivated vaccine.

  • EXPERTS SAY H1N1 VACCINES INVALUABLE.  // Materials Management in Health Care;Feb2010, Vol. 19 Issue 2, p5 

    The article reports on the open letter of health care organizations, professional associations and government agencies which urges the citizens to be immunized against H1N1 influenza in the U.S.

  • Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin. Weaver, Eric A.; Rubrum, Adam M.; Webby, Richard J.; Barry, Michael A. // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    Influenza poses a persistent worldwide threat to the human population. As evidenced by the 2009 H1N1 pandemic, current vaccine technologies are unable to respond rapidly to this constantly diverging pathogen. We tested the utility of adenovirus (Ad) vaccines expressing centralized consensus...

  • The inequality of H1N1 vaccination regulations for children. Johnston, Jane // British Journal of Nursing;2/8/2011, Vol. 20 Issue 3, p191 

    A letter to the editor is presented which is concerned with H1N1 influenza vaccination regulations for children.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics